WSA
VTVT icon

Wall Street Associates’s vTv Therapeutics VTVT Stock Holding History

Wall Street Associates’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$797K Sell
4,123
-1,977
-32% -$454K 0.53% 70
2016
Q3 		$1.75M Hold
6,100
– – 0.6% 76
2016
Q2 		$1.42M Hold
6,100
– – 0.57% 71
2016
Q1 		$1.26M Hold
6,100
– – 0.52% 80
2015
Q4 		$1.66M Hold
6,100
– – 0.47% 70
2015
Q3 		$1.59M Buy
+6,100
New +$2.13M 0.3% 100

Other funds holding VTVT

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wall Street Associates's VTVT Position: Q4 2016 in Review

Wall Street Associates reduced its vTv Therapeutics (VTVT) stake by 32% in Q4 2016, selling an estimated $454K and leaving 4,123 shares worth $797K. The position accounts for 0.53% of the portfolio, ranked #70.

Wall Street Associates first reported a position in VTVT in Q3 2015 and has held it in 6 quarters since. The position peaked at $1.75M in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

  • Wall Street Associates held 4,123 shares of vTv Therapeutics worth $797K as of Q4 2016.
  • Wall Street Associates sold 1,977 vTv Therapeutics shares in Q4 2016, an estimated $454K.
  • vTv Therapeutics made up 0.53% of Wall Street Associates's portfolio in Q4 2016, its #70 holding.
  • Wall Street Associates first reported a position in vTv Therapeutics in Q3 2015 and has held it in 6 quarters since.
  • Wall Street Associates's vTv Therapeutics position peaked at $1.75M in Q3 2016.
  • 44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.